Page 2 - அமீத் மல்லிக் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அமீத் மல்லிக். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அமீத் மல்லிக் Today - Breaking & Trending Today

Rafael Holdings Reports Third Quarter Fiscal Year 2021 Results

Rafael Holdings Reports Third Quarter Fiscal Year 2021 Results
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Fordoz Pharma , Howard Jonas , Rafael Pharma , Third Party , American Society Of Clinical Oncology , Lipomedix Pharmaceuticals Ltd , Rafael Pharmaceuticals , Rafael Holdings Inc , Barer Institute , Rafael Pharmaceuticals Inc , Investment In Rafael Pharmaceuticals , Rp Finance , Other Pharmaceuticals , Rafael Holdings , Consolidated Financial , Chief Executive Officer , Chief Commercial , Pharmaceutical Holdings , Clinical Oncology , Annual Meeting , Ameet Mallik , Lipomedix Pharmaceuticals , Months Ended April , Hedge Funds , ஒன்றுபட்டது மாநிலங்களில் ,

Rafael Holdings Announces Inducement Grant Under NYSE Rule 303A.08

/PRNewswire/ Rafael Holdings, Inc., (NYSE: RFL), today announced that, on May 27, 2021, it made a grant to Ameet Mallik, Rafael Holdings Chief Executive. ....

Compensation Committee Of The Board Directors , Company On , York Stock Exchange Rule , Company Class , Rafael Holdings Inc , Rafael Holding , Rafael Holdings , Ameet Mallik , Rafael Holding Chief Executive Officer , New York Stock Exchange Rule , Compensation Committee , Chief Executive Officer , இழப்பீடு குழு ஆஃப் தி பலகை இயக்குநர்கள் , நிறுவனம் ஆன் , யார்க் ஸ்டாக் பரிமாற்றம் ஆட்சி , நிறுவனம் வர்க்கம் , ரஃபேல் ஹோல்டிங்ஸ் இன்க் , ரஃபேல் வைத்திருத்தல் , ரஃபேல் ஹோல்டிங்ஸ் , அமீத் மல்லிக் , புதியது யார்க் ஸ்டாக் பரிமாற்றம் ஆட்சி , இழப்பீடு குழு , தலைமை நிர்வாகி அதிகாரி ,

Old West: "Investment in Rafael Holdings (RFL) Represents an Extremely Asymmetric Opportunity"

Old West: “Investment in Rafael Holdings (RFL) Represents an Extremely Asymmetric Opportunity”
Old West Investment Management, an investment management firm, published its first quarter 2021 investor letter – a copy of which can be downloaded here. An average return of 25% was delivered by the fund for the Q1 of 2021, ahead of its S&P 500 benchmark that delivered a 6% return for the same period. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.
Old West Investment Management, in their Q1 2021 investor letter, mentioned Rafael Holdings, Inc. (NYSE: RFL), and shared their insights on the company. Rafael Holdings, Inc. is a Newark, New Jersey-based clinical-stage oncology pharmaceutical company that currently has a $682.7 million market capitalization. Since the beginning of the year, RFL delivered an impressive 76.72% return, extending its 12-month gains to 192.06%. As of April 28, 2021, the stock closed at $41.38 per share. ....

South Korea , Howard Jonas , Sanjeev Luther , Alberto Gabizon , Kalinovskiy Shutterstock , Sol Barer , Chi Van Dang , Rafael Pharma , Richard Axel , Rafael Pharmaceuticals , Investment Company , Abramson Cancer Center , Rafael Holdings Inc , Barer Institute , Rafael Holdings On , Rafael Holdings , Rafael Holding , Federal Reserve , Columbia University , Wake Forest Baptist Medical Center , Wake Forest Baptist University , Association Of Southeast Asian Nations , University Of Pennsylvania , Cornerstone Pharmaceuticals , World Class Management Team , Old West Investment Management ,

Rafael Holdings Reports Second Quarter Fiscal Year 2021 Results

Rafael Holdings Reports Second Quarter Fiscal Year 2021 Results
News provided by
Share this article
Share this article
NEWARK, N.J., March 17, 2021 /PRNewswire/ Rafael Holdings, Inc., (NYSE: RFL), reported revenue of $1.0 million and a loss per share of $0.50 for the second quarter of its 2021 fiscal year, the three months ended January 31, 2021.
Q2 FY 2021 Consolidated Financial and Operational Highlights
Revenue of $1.0 million, generated by Rafael Holdings real estate portfolio, decreased from $1.2 million in the year-ago quarter due, in part, to the sale of its building in Piscataway, NJ.
Loss per share of $0.50 compared to a loss per share of $0.08 in the year ago quarter primarily due to a $7.0 million impairment of the company s interest in Altira, as described below. ....

United States , Howard Jonas , Fordoz Pharma , Joshua Rabinowitz , Third Party , Sarcoma Alliance For Research , Lipomedix Pharmaceuticals Ltd , Rafael Pharmaceuticals , Princeton University Office Of Technology Licensing , Rafael Holdings Inc , Barer Institute , Rafael Pharmaceuticals Inc , Investment In Rafael Pharmaceuticals , Rp Finance , Rafael Holdings , Drug Administration , Rafael Holding , Department Of Chemistry , Company Class , Other Pharmaceuticals , Rafael Holding Board Of Directors , Holding Board , Ameet Mallik , Chief Executive Office , Rafael Holding Chief Commercial , Rafael Pharmaceutical ,

Rafael Holdings Enhances Senior Management Team with Additions of Ameet Mallik, CEO and William Conkling, CCO

Rafael Holdings Enhances Senior Management Team with Additions of Ameet Mallik, CEO and William Conkling, CCO
Leadership Team Will Build on Pharma Investments
News provided by
Share this article
Share this article
NEWARK, N.J., March 11, 2021 /PRNewswire/ Rafael Holdings, Inc., (NYSE: RFL), today announced that its Board of Directors has recruited Ameet Mallik to become the company s Chief Executive Officer, succeeding its founder, Howard Jonas. Ameet Mallik s appointment will become effective May 1, 2021. In addition, William Bill Conkling has been named Chief Commercial Officer effective March 15, 2021.
Ameet Mallik will join Rafael Holdings from Novartis where he is currently Executive Vice President and Head, U.S. Oncology, responsible for Novartis s commercial and medical oncology operations in the United States. ....

United States , Howard Jonas , Rafael Pharma , Lipomedix Pharmaceuticals Ltd , Fordham University , Rafael Holdings Inc , Barer Institute , Rafael Pharmaceuticals Inc , York University Stern School Of Business , Wharton School , Health Section Governing Board , University Of Pennsylvania , Northwestern University , Rafael Holdings , Ameet Mallik , Chief Executive Officer , Chief Commercial Officer , Executive Vice President , Bill Conkling , Global Head , Latin America , Strategic Planning , Associate Principal , Chemical Engineering , Vice President Sales , Market Access ,